These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6276786)

  • 21. On the relation between haloperidol-induced alterations in DA release and DA metabolism in rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    Life Sci; 1978 Aug; 23(6):611-5. PubMed ID: 692284
    [No Abstract]   [Full Text] [Related]  

  • 22. Haloperidol inhibits the disappearance of acidic dopamine metabolites from rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    J Pharm Pharmacol; 1978 Sep; 30(9):583-5. PubMed ID: 29101
    [No Abstract]   [Full Text] [Related]  

  • 23. Reduced haloperidol: effects on striatal dopamine metabolism and conversion to haloperidol in the rat.
    Korpi ER; Wyatt RJ
    Psychopharmacology (Berl); 1984; 83(1):34-7. PubMed ID: 6204352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of stimulated dopamine release from striatum slices after hemorrhagic shock in the rat. Protective effect of piracetam.
    Grässler J; Wustmann C; Fischer HD; Schmidt J; Scheuch DW
    Methods Find Exp Clin Pharmacol; 1987 Aug; 9(8):489-91. PubMed ID: 3695732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral and biochemical correlates after haloperidol and clozapine long-term treatment.
    Racagni G; Bruno F; Bugatti A; Parenti M; Apud JA; Santini V; Carenzi A; Groppetti A; Cattabeni F
    Adv Biochem Psychopharmacol; 1980; 24():45-51. PubMed ID: 7405672
    [No Abstract]   [Full Text] [Related]  

  • 26. Choline and physostigmine enhance haloperidol-induced HVA and DOPAC accumulation.
    Millington WR; Wurtman RJ
    Eur J Pharmacol; 1982 Jun; 80(4):431-4. PubMed ID: 7106193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cyclo (Leu-Gly) on neurochemical indices of striatal dopaminergic supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Fage D; Scatton B
    Life Sci; 1984 Jan; 34(4):393-9. PubMed ID: 6694528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of piracetam on brain monoamine metabolism and serum prolactin levels in the rat.
    Nybäck H; Wiesel FA; Skett P
    Psychopharmacology (Berl); 1979 Mar; 61(3):235-8. PubMed ID: 109886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics.
    Ladinsky H; Consolo S; Samanin R; Algeri S; Ponzio F
    Adv Biochem Psychopharmacol; 1980; 24():259-65. PubMed ID: 7405665
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of phencyclidine on dopamine synthesis and metabolic in rat striatum.
    Doherty JD; Simonovic M; So R; Meltzer HY
    Eur J Pharmacol; 1980 Jul; 65(2-3):139-49. PubMed ID: 7398783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion.
    Salamone JD; Keller RW; Zigmond MJ; Stricker EM
    Brain Res; 1989 May; 487(2):215-24. PubMed ID: 2786443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.
    Lannes B; Micheletti G; Warter JM; Kempf E; Di Scala G
    Neurosci Lett; 1991 Jul; 128(2):177-81. PubMed ID: 1945038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased release of striatal dopamine after long-term treatment with methadone in rats: inhibition by agents which increase central 5-hydroxytryptamine transmission.
    Spampinato U; Nowakowska E; Samanin R
    J Pharm Pharmacol; 1983 Dec; 35(12):831-3. PubMed ID: 6141252
    [No Abstract]   [Full Text] [Related]  

  • 35. Catalepsy induced by striatal acetylcholinesterase inhibition with fasciculin in rats.
    Castelló ME; Bolioli B; Dajas F
    Pharmacol Biochem Behav; 1992 Mar; 41(3):547-50. PubMed ID: 1584833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo voltammetric investigations into the action of HA-966 on central dopaminergic neurons.
    Mos J; Broxterman HJ; van Bennekom WP
    Brain Res; 1981 Mar; 207(2):465-70. PubMed ID: 7470915
    [No Abstract]   [Full Text] [Related]  

  • 37. Lack of tolerance to ethanol-induced dopamine release in the rat ventral striatum.
    Rossetti ZL; Hmaidan Y; Diana M; Gessa GL
    Eur J Pharmacol; 1993 Feb; 231(2):203-7. PubMed ID: 8453975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
    See RE
    Neurosci Lett; 1991 Aug; 129(2):265-8. PubMed ID: 1720879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a psychostimulant drug sydnocarb on rat brain dopaminergic transmission in vivo.
    Gainetdinov RR; Sotnikova TD; Grekhova TV; Rayevsky KS
    Eur J Pharmacol; 1997 Dec; 340(1):53-8. PubMed ID: 9527506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of striatal dopaminergic grafts by haloperidol.
    Herman JP; Choulli K; Le Moal M
    Brain Res Bull; 1985 Dec; 15(6):543-6. PubMed ID: 3936594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.